BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37310446)

  • 1. The 5-HT
    Papp M; Gruca P; Lason M; Litwa E; Newman-Tancredi A; Depoortère R
    Psychopharmacology (Berl); 2023 Nov; 240(11):2419-2433. PubMed ID: 37310446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical 5-hydroxytryptamine 1A receptor biased agonist, NLX-101, displays rapid-acting antidepressant-like properties in the rat chronic mild stress model.
    Depoortère R; Papp M; Gruca P; Lason-Tyburkiewicz M; Niemczyk M; Varney MA; Newman-Tancredi A
    J Psychopharmacol; 2019 Nov; 33(11):1456-1466. PubMed ID: 31290370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5-HT1A receptor biased agonists, NLX-204 and NLX-101, like ketamine, elicit rapid-acting antidepressant activity in the rat chronic mild stress model via cortical mechanisms.
    Papp M; Gruca P; Litwa E; Lason M; Newman-Tancredi A; Depoortère R
    J Psychopharmacol; 2024 Jun; ():2698811241254832. PubMed ID: 38825869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT
    Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
    Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of Serotonin 5-HT
    Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of Affective Illness: Chronic Mild Stress in the Rat.
    Papp M; Willner P
    Curr Protoc; 2023 Mar; 3(3):e712. PubMed ID: 36892313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
    Willner P; Gruca P; Lason M; Tota-Glowczyk K; Litwa E; Niemczyk M; Papp M
    Behav Pharmacol; 2019 Apr; 30(2 and 3-Spec Issue):239-250. PubMed ID: 30204592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLX-101, a highly selective 5-HT
    Depoortère R; Auclair AL; Newman-Tancredi A
    Behav Brain Res; 2021 Mar; 401():113082. PubMed ID: 33358917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating biased agonists from molecules to medications: Serotonin 5-HT
    Newman-Tancredi A; Depoortère RY; Kleven MS; Kołaczkowski M; Zimmer L
    Pharmacol Ther; 2022 Jan; 229():107937. PubMed ID: 34174274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective 5-HT
    Głuch-Lutwin M; Sałaciak K; Gawalska A; Jamrozik M; Sniecikowska J; Newman-Tancredi A; Kołaczkowski M; Pytka K
    Psychopharmacology (Berl); 2021 Aug; 238(8):2249-2260. PubMed ID: 33973045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
    Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
    Iderberg H; McCreary AC; Varney MA; Kleven MS; Koek W; Bardin L; Depoortère R; Cenci MA; Newman-Tancredi A
    Exp Neurol; 2015 Sep; 271():335-50. PubMed ID: 26037043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological MRI to investigate the functional selectivity of 5-HT
    Vidal B; Bolbos R; Redouté J; Langlois JB; Costes N; Newman-Tancredi A; Zimmer L
    Neuropharmacology; 2020 Aug; 172():107867. PubMed ID: 31783063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
    Jastrzębska-Więsek M; Wesołowska A; Kołaczkowski M; Varney MA; Newman-Tancredi A; Depoortere R
    Behav Pharmacol; 2022 Aug; 33(5):333-341. PubMed ID: 35695543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT
    Depoortère R; Bardin L; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2019 Jul; 10(7):3101-3107. PubMed ID: 30929419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective 5-HT
    Powell WH; Annett LE; Depoortere R; Newman-Tancredi A; Iravani MM
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Feb; 395(2):149-157. PubMed ID: 34821958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLX-101, a cortical 5-HT
    Depoortere RY; Auclair AL; Newman-Tancredi A
    Brain Res; 2021 Aug; 1765():147493. PubMed ID: 33887253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nelumbinis Semen reverses a decrease in 5-HT1A receptor binding induced by chronic mild stress, a depression-like symptom.
    Jang CG; Kang M; Cho JH; Lee SB; Kim H; Park S; Lee J; Park SK; Hong M; Shin MK; Shim IS; Bae H
    Arch Pharm Res; 2004 Oct; 27(10):1065-72. PubMed ID: 15554266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of 5-HT
    Aguiar RP; Soares LM; Meyer E; da Silveira FC; Milani H; Newman-Tancredi A; Varney M; Prickaerts J; Oliveira RMW
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109832. PubMed ID: 31809832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.